» Articles » PMID: 29949048

Systematic Review and Meta-Analysis of the Prognostic Significance of Neutrophil-Lymphocyte Ratio (NLR) After R0 Gastrectomy for Cancer

Overview
Publisher Springer
Date 2018 Jun 28
PMID 29949048
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: A meta-analysis was performed to evaluate the prognostic value of neutrophil-lymphocyte ratio (NLR) in patients undergoing potentially curative gastrectomy for cancer (GC).

Methods: Thomson Reuters Web of Science, Ovid MEDLINE(R) and PUBMED databases were searched for relevant articles using search terms neutrophil-lymphocyte ratio (NLR), GC and survival. Articles reporting overall survival (OS), cancer-specific survival and disease-free survival (DFS), in patients undergoing R0 gastrectomy, were studied.

Results: Articles numbering 365 were identified during the preliminary search, and 10 containing 4164 patients were included in the final review. Most patients were > 60 years of age, male (67%) and 2239 (53.8%) had pT3 disease. The number of NLR dichotomization thresholds reported numbered 7, with 2.00 and 3.00 (n = 2) the most common. NLR was associated with poor survival in eight studies with hazard ratios ranging from 1.54 (95% confidence interval (CI) 1.26-1.89) to 2.99 (1.99-4.49). Pooled odds ratio (OR) for OS was 2.31 (1.40-3.83, p = 0.001) and for DFS 2.72 (1.14-6.54, p = 0.020). Four studies presented T-stage data, OR 1.62 (1.33-1.96, p < 0.001).

Conclusion: NLR is an important prognostic indicator associated with both OS and DFS after R0 resection of GC, but the critical level is equivocal.

Citing Articles

Baseline (derived) neutrophil-lymphocyte ratio associated with survival in gastroesophageal junction or gastric cancer treated with ICIs.

Yu C, Jiang H, Wang L, Jiang Z, Jin C Front Oncol. 2025; 15:1404695.

PMID: 39926278 PMC: 11802431. DOI: 10.3389/fonc.2025.1404695.


Neutrophil/Lymphocyte Ratio as a Biomarker of Response to H1-Antihistamine Therapy in Patients with Chronic Spontaneous Urticaria.

Qiu X, Ran Q, Pan J, Tan G Indian J Dermatol. 2024; 69(5):367-370.

PMID: 39649971 PMC: 11623418. DOI: 10.4103/ijd.ijd_558_22.


Dysregulation of systemic immunity and its clinical application in gastric cancer.

Zhang Y, Li J, Li J, Wang J Front Immunol. 2024; 15:1450128.

PMID: 39301031 PMC: 11410619. DOI: 10.3389/fimmu.2024.1450128.


Predictive model for prolonged hospital stay risk after gastric cancer surgery.

Zhang X, Wei X, Lin S, Sun W, Wang G, Cheng W Front Oncol. 2024; 14:1382878.

PMID: 39165684 PMC: 11333226. DOI: 10.3389/fonc.2024.1382878.


Construction of a predictive model for acute liver failure after hepatectomy based on neutrophil-to-lymphocyte ratio and albumin-bilirubin score.

Li X, Bao Z, Wang L, Zhang C, Yang W World J Gastrointest Surg. 2024; 16(4):1087-1096.

PMID: 38690037 PMC: 11056668. DOI: 10.4240/wjgs.v16.i4.1087.


References
1.
Templeton A, McNamara M, Seruga B, Vera-Badillo F, Aneja P, Ocana A . Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106(6):dju124. DOI: 10.1093/jnci/dju124. View

2.
Tamhane U, Aneja S, Montgomery D, Rogers E, Eagle K, Gurm H . Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008; 102(6):653-7. DOI: 10.1016/j.amjcard.2008.05.006. View

3.
Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M . Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis. Ann Surg Oncol. 2015; 23(2):646-54. DOI: 10.1245/s10434-015-4869-5. View

4.
Jung M, Park Y, Jeong O, Seon J, Ryu S, Kim D . Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol. 2011; 104(5):504-10. DOI: 10.1002/jso.21986. View

5.
Yang J, Hu Z, Shi W, Deng T, He S, Yuan S . Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015; 21(9):2807-15. PMC: 4351235. DOI: 10.3748/wjg.v21.i9.2807. View